LYEL
Lyell Immunopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.37
+0.35%Leverage
- Debt / equity
- 0.16x
- Net debt / equity
- -0.15x
- Debt / assets
- 0.12x
- Debt / EBITDA
- -0.15x
- Net debt / EBITDA
- 0.15x
Liquidity & coverage
- Current ratio
- 5.36x
- Quick ratio
- 5.36x
- Cash ratio
- 5.12x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $173.7M
Cash & dividend
- FCF / debt
- -3.63x
- Cash flow / debt
- -3.61x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026